載入...
Ra223 in Bone Metastases with Osteolytic Activity
Radium 223 dichloride (Ra223) is the only targeted alpha therapy able to extend survival in patients with bone metastases from prostate cancer. Mechanism of action and data currently available focused mainly on osteoblastic metastases from prostate cancer. In our institution, a patient with breast c...
Na minha lista:
| 發表在: | World J Nucl Med |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905256/ https://ncbi.nlm.nih.gov/pubmed/29719487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/wjnm.WJNM_22_17 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|